Related references
Note: Only part of the references are listed.Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals
Ahmed Fayed et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
LDL particle size and antioxidant HDL function improve after sustained virological response in patients with chronic HCV
Jose Ignacio Vargas et al.
ANNALS OF HEPATOLOGY (2022)
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Adherence to regular surveillance visits for hepatocellular carcinoma in patients with chronic hepatitis C virus infection who achieved sustained virologic response
Hidenori Toyoda et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2022)
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort
Loreta A. Kondili et al.
HEPATOLOGY (2022)
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
Georg Semmler et al.
JOURNAL OF HEPATOLOGY (2022)
End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma
Ruben Hernaez et al.
GUT (2022)
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
Victor Sapena et al.
GUT (2022)
Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
Mahmood Danishwar et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
Paul Martin et al.
KIDNEY INTERNATIONAL (2022)
HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus
Marina Angel et al.
BMC ENDOCRINE DISORDERS (2022)
Breakthroughs in hepatitis C research: from discovery to cure
Michael P. Manns et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
Direct-Acting Antiviral Agents for Hepatitis C Virus Infection-From Drug Discovery to Successful Implementation in Clinical Practice
Christopher Dietz et al.
VIRUSES-BASEL (2022)
Non-invasive tests for clinically significant portal hypertension after HCV cure
Georg Semmler et al.
JOURNAL OF HEPATOLOGY (2022)
Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension
Heba Ahmed Faheem et al.
EGYPTIAN LIVER JOURNAL (2022)
Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study
Marina Serper et al.
LIVER INTERNATIONAL (2021)
Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity
Lisette A. P. Krassenburg et al.
JOURNAL OF HEPATOLOGY (2021)
Diabetes Mellitus Increases the Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy: Systematic Review and Meta-Analysis
Szilard Vancsa et al.
FRONTIERS IN MEDICINE (2021)
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort
Vincenza Calvaruso et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes
Ferdinando Carlo Sasso et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)
Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response
Claudia Montaldo et al.
JOURNAL OF HEPATOLOGY (2021)
Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study
Viola Knop et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness
Elton Dajti et al.
JHEP REPORTS (2021)
Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease
Meghan E. Sise et al.
KIDNEY INTERNATIONAL (2020)
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals
Monica Pons et al.
JOURNAL OF HEPATOLOGY (2020)
Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents
Manuel Mendizabal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
HEPATOLOGY (2020)
Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance
Francesco Paolo Russo et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Postsustained Virological Response Management in Hepatitis C Patients
Chiara Masetti et al.
SEMINARS IN LIVER DISEASE (2020)
Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients
Man Yuan et al.
SCIENTIFIC REPORTS (2020)
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis
Angelo Sangiovanni et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Sabela Lens et al.
JOURNAL OF HEPATOLOGY (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat et al.
LANCET (2019)
The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection
Hashem B. El-Serag et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
Elisabetta Degasperi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Exosomal Transmission of MicroRNA from HCV Replicating Cells Stimulates Transdifferentiation in Hepatic Stellate Cells
Ji Hyun Kim et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy
N. Saraiya et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients
Patrice Cacoub et al.
AMERICAN HEART JOURNAL (2018)
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Raymond T. Chung et al.
CLINICAL INFECTIOUS DISEASES (2018)
Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure
Martin Bonacci et al.
GASTROENTEROLOGY (2018)
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen
Hamish Innes et al.
JOURNAL OF HEPATOLOGY (2018)
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2018)
Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis
T. Sinegre et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals
Francesco Paolo Russo et al.
LIVER INTERNATIONAL (2018)
Changing Concepts of Cirrhotic Coagulopathy
Armando Tripodi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon et al.
GASTROENTEROLOGY (2017)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal et al.
GASTROENTEROLOGY (2017)
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
Adriaan J. van der Meer et al.
JOURNAL OF HEPATOLOGY (2017)
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
Reem Waziry et al.
JOURNAL OF HEPATOLOGY (2017)
Exosome Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells (vol 91, e02225-16, 2017)
Pradip B. Devhare et al.
JOURNAL OF VIROLOGY (2017)
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
M. Bourliere et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hepatitis C virus and cardiovascular: A review
Salvatore Petta
JOURNAL OF ADVANCED RESEARCH (2017)
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase
Ju Dong Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies
Salvatore Petta et al.
GASTROENTEROLOGY (2016)
APASL consensus statements and recommendation on treatment of hepatitis C
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2016)
Hepatitis C virus infection and chronic kidney disease: Time for reappraisal
Patrice Cacoub et al.
JOURNAL OF HEPATOLOGY (2016)
High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
Helder Cardoso et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment
Karin Kozbial et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis
J. Peveling-Oberhag et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Fabrizio Fabrizi et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
Ching-Sheng Hsu et al.
SCIENTIFIC REPORTS (2015)
Natural history of hepatitis C
Rachel H. Westbrook et al.
JOURNAL OF HEPATOLOGY (2014)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
Pegylated Interferon-α2a Inhibits Proliferation of Human Liver Cancer Cells In Vitro and In Vivo
Hironori Kusano et al.
PLOS ONE (2013)
Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
Mei-Hsuan Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Sustained Virologic Response Prevents the Development of Esophageal Varices in Compensated, Child-Pugh Class A Hepatitis C Virus-Induced Cirrhosis. A 12-Year Prospective Follow-up Study
Savino Bruno et al.
HEPATOLOGY (2010)
Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: Comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients
Fumio Imazeki et al.
LIVER INTERNATIONAL (2008)
Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis
Stuart Roberts et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Diabetes mellitus reduces the therapeutic effectiveness of interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
Ichiro Konishi et al.
HEPATOLOGY RESEARCH (2007)
Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection
F Visnegarwala et al.
JOURNAL OF INFECTION (2005)
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
M Romero-Gómez et al.
GASTROENTEROLOGY (2005)
Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: A population-based cohort study
H Watanabe et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population
LA Kondili et al.
GUT (2002)
Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation
DL Bigam et al.
HEPATOLOGY (2000)